AAD 2026: Revance to Showcase Expanding Aesthetics Portfolio
Key Takeaways
- Revance will present its full aesthetics, regenerative, and skincare portfolio at AAD 2026.
- The company is highlighting injectables, microneedling devices, and consumer skincare brands.
- Programming includes physician-led sessions and collaboration with AIRE Health.
Revance Therapeutics Inc. announced it will showcase its expanding portfolio of aesthetics, regenerative medicine, and consumer skincare products at the 2026 American Academy of Dermatology (AAD) Annual Meeting, scheduled for March 26–31 in Denver, Colorado. The company plans a series of in-booth educational sessions and networking events aimed at reinforcing its engagement with the dermatology community.
The portfolio on display includes the DAXXIFY injectable, the Teoxane RHA Collection of dermal fillers, and the SkinPen microneedling device. Scheduled booth presentations are listed below:
- Diane Berson, MD - DAXXIFY® brand injectable and the Teoxane RHA® Collection (Friday, 3/27 at 12:00PM)
- Michael Gold, MD - SkinPen® microneedling devices (Friday, 3/27 at 12:30PM)
- Ava Shamban, MD - DAXXIFY® (Saturday, 3/28 at 12:00PM)
- Jody Comstock, MD - the Teoxane RHA® Collection and the Teoxane MLT Multilayering Technique™ (Saturday, 3/28 at 12:30PM)
- Suneel Chilukuri, MD, FAAD, FACMS – SkinPen® (Saturday, 3/28 at 1:00PM)
Revance is also highlighting its consumer skincare segment, including products from PanOxyl, Blue Lizard, StriVectin, and Sarna. New formulations such as antimicrobial mists, ceramide-based barrier creams, and post-sun care products will be featured, with samples distributed during the meeting.
In collaboration with AIRE Health, a platform founded by Dhaval Bhanusali, MD, and Muneeb Shah, MD, Revance will host programming focused on physician involvement in brand development and industry partnerships.
"We are incredibly excited to be at AAD this year and to share the progress Revance has made across our entire aesthetics, regenerative and skincare portfolio," said Nadeem Moiz, CEO of Revance. "As a company, we pride ourselves on driving innovation beyond convention in dermatology and believe that science-powered innovation creates new clinical possibilities. The AAD Annual Meeting provides an important opportunity to connect with the dermatology community, exchange ideas, and highlight new innovations shaping the future of aesthetics, regenerative and skin health. Furthermore, we are thrilled to partner with Dr. Bhanusali, Dr. Shah, and the AIRE Health team to expand awareness of the Revance skincare portfolio that serves the dermatology community and its patients."